Filter by: patients
What is Trimipramine?

Trimipramine is a tricyclic antidepressant with sedating effects. It is used to treat depression.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Depressed mood 4 1 Efficacy_slight
Stress 1 0
Anxious mood 1 1 Efficacy_slight
Emotional lability 1 0
Sleep problems 1 1 Efficacy_moderate
Eating disorder symptoms 1 0

See all 6 patients currently taking Trimipramine

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
0
Moderate
0
Mild
3
None
1

Commonly reported side effects, conditions, and hospitalizations associated with Trimipramine

Dry mouth (xerostomia) 1

Reported Dosages

  10 mg daily 50 mg daily 75 mg daily 100 mg daily 150 mg daily
  1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking Trimipramine (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work 2   Did not seem to work: 67%
Other 1   Other: 33%
Not indicated 1   Not indicated: 33%

See all 3 patients who’ve stopped taking Trimipramine

Currently Taking Trimipramine

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Stopped Taking Trimipramine

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Adherence of Trimipramine

Always
3 75%
Usually
1 25%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Burden of Trimipramine

Very
0 0%
Somewhat
1 25%
A little
1 25%
Not at all
2 50%

Cost

Paid out of pocket

Cost of Trimipramine

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
1 100%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 24, 2012.